Macrophage COX-2 prevents diabetic nephropathy progression

Macrophage COX-2 prevents diabetic nephropathy progression

(HealthDay)—Macrophage cyclooxygenase-2 (COX-2) deletion is associated with progression of diabetic nephropathy (DN), according to an experimental study published online Nov. 4 issue of Diabetes.

Xin Wang, from the Vanderbilt University School of Medicine in Nashville, Tenn., and colleagues examined the effects of macrophage COX-2 on development of DN in a mouse model of type 1 diabetes.

The researchers found that cultured macrophages with deletion of COX-2 exhibited a proinflammatory "M1" phenotype, with higher inducible nitric oxide synthase and NF-κB levels, but lower levels of interleukin-4Rα. Mice with COX-2 deletion in hematopoietic or macrophages developed severe DN compared with corresponding wild type diabetic mice, as indicated by increased albuminuria; fibrosis; and renal infiltration of T cells, neutrophils, and macrophages. Diabetic kidneys with macrophage COX-2 deletion had more infiltration of macrophages, but fewer renal "M2" (reparative phenotype); they also had increased ER stress and decreased numbers of podocytes. Results were similar in diabetic with macrophage E4 deletion.

"These studies have demonstrated an important but unexpected role for macrophage COX-2/PGE2/EP4 signaling to lessen progression of , unlike the pathogenic effects of increased COX-2 expression in intrinsic renal cells," the authors write.


Explore further

Insulin resistance reversed by removal of protein

More information: Full Text (subscription or payment may be required)
Journal information: Diabetes

Copyright © 2016 HealthDay. All rights reserved.

Citation: Macrophage COX-2 prevents diabetic nephropathy progression (2016, November 9) retrieved 19 October 2019 from https://medicalxpress.com/news/2016-11-macrophage-cox-diabetic-nephropathy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more